Prednisolone: Difference between revisions
No edit summary
Line 5: Line 5:


==Adult Dosing==
==Adult Dosing==
'''corticosteroid-responsive conditions''': 5-60 mg/day PO divided qd-qid
===Corticosteroid-responsive conditions===
*5-60 mg/day PO divided qd-qid


'''asthma, acute''': ED/hospital: 40-80 mg/day PO divided qd-bid, cont. until peak flow = 70% predicted; Outpatient burst tx: 40-60 mg/day PO divided qd-bid x 3-10 days
===[[Asthma]], acute===
*ED/hospital: 40-80 mg/day PO divided qd-bid, cont. until peak flow = 70% predicted
*Outpatient burst tx: 40-60 mg/day PO divided qd-bid x 3-10 days


'''asthma, severe persistent''': 7.5-60 mg PO qd-qod
===[[Asthma]], severe persistent===
*7.5-60 mg PO qd-qod


'''adrenal insufficiency''': 4-5 mg/m^2 PO qd
===[[Adrenal insufficiency]]===
*4-5 mg/m^2 PO qd


'''multiple sclerosis, acute exacerbation''': 200 mg PO qd x 1 wk, then 80 mg PO qod x 1 mo
===[[Multiple sclerosis]], acute exacerbation===
*200 mg PO qd x 1 wk, then 80 mg PO qod x 1 mo


'''alcoholic hepatitis, acute''': 40 mg PO qd
===[[Alcoholic hepatitis]], acute===
*40 mg PO qd


==Pediatric Dosing==
==Pediatric Dosing==
'''corticosteroid-responsive conditions''': 0.14-2 mg/kg/day PO divided qd-qid
===Corticosteroid-responsive conditions===
*0.14-2 mg/kg/day PO divided qd-qid


'''asthma, acute''': ED/hospital: 1-2 mg/kg/day PO divided qd-bid, Max: 60 mg/day, cont. until peak flow = 70% predicted; Outpatient burst tx: 1-2 mg/kg/day PO divided qd-bid x 3-10 days, Max: 60 mg/day
===[[Asthma]], acute===
*ED/hospital: 1-2 mg/kg/day PO divided qd-bid
*Max: 60 mg/day, cont. until peak flow = 70% predicted
*Outpatient burst tx: 1-2 mg/kg/day PO divided qd-bid x 3-10 days
*Max: 60 mg/day


'''asthma, severe persistent''': 0.25-2 mg/kg PO qd-qod, Max 60 mg/day
===[[Asthma]], severe persistent===
*0.25-2 mg/kg PO qd-qod
*Max 60 mg/day


'''adrenal sufficiency''': 4-5 mg/m^2 PO qd
===[[Adrenal insufficiency]]===
*4-5 mg/m^2 PO qd


'''nephrotic syndrome''': 60 mg/m^2/day PO divided tid x 4 wk, then 40 mg/m^2 PO qod x 4 wk
===[[Nephrotic syndrome]]===
*60 mg/m^2/day PO divided tid x 4 wk, then 40 mg/m^2 PO qod x 4 wk


==Special Populations==
==Special Populations==
Line 45: Line 61:
*avoid abrupt withdrawal (high dose or long-term use)
*avoid abrupt withdrawal (high dose or long-term use)
*caution if active infection
*caution if active infection
*caution if TB infection
*caution if [[TB]] infection
*caution if ocular HSV
*caution if ocular HSV
*caution if immunosuppressed
*caution if immunosuppressed
Line 72: Line 88:
*immunosuppression
*immunosuppression
*infection
*infection
*HTN
*[[HTN]]
*CHF
*[[CHF]]
*diabetes mellitus
*[[diabetes mellitus]]
*steroid psychosis
*steroid psychosis
*GI perforation/ulcer
*GI perforation/ulcer
Line 83: Line 99:
*pseudotumor cerebri
*pseudotumor cerebri
*ICP incr.
*ICP incr.
*seizures
*[[seizures]]
*glaucoma
*glaucoma
*cataracts
*cataracts
*pancreatitis
*[[pancreatitis]]
*growth suppression (long-term use, peds pts)
*growth suppression (long-term use, peds pts)
*exophthalmos
*exophthalmos
*anaphylaxis
*[[anaphylaxis]]
*withdrawal sx if abrupt D/C (high dose or long-term use)
*withdrawal sx if abrupt D/C (high dose or long-term use)


Line 95: Line 111:
*sodium and fluid retention
*sodium and fluid retention
*diaphoresis
*diaphoresis
*headache
*[[headache]]
*vertigo
*[[vertigo]]
*insomnia
*insomnia
*nervousness
*nervousness
Line 107: Line 123:
*facial erythema
*facial erythema
*menstrual irregularities
*menstrual irregularities
*hypokalemia
*[[hypokalemia]]
*IOP incr.
*IOP incr.
*impaired wound healing (long-term use)
*impaired wound healing (long-term use)
Line 113: Line 129:
*skin pigmentation abnormality
*skin pigmentation abnormality
*hirsutism
*hirsutism
*urticaria
*[[urticaria]]


==Pharmacology==
==Pharmacology==
Line 123: Line 139:
==See Also==
==See Also==


==Sources==
==References==
 
<references/>
<references/>
[[Category:Drugs]]
[[Category:Drugs]]

Revision as of 13:40, 4 August 2015

General

  • Type: Corticosteroid
  • Dosage Forms: 5; 5,15,25/5 mL
  • Common Trade Names: Flo-Pred, Millipred, Oraped, Pedipred, Prelone, Veripred 20

Adult Dosing

Corticosteroid-responsive conditions

  • 5-60 mg/day PO divided qd-qid

Asthma, acute

  • ED/hospital: 40-80 mg/day PO divided qd-bid, cont. until peak flow = 70% predicted
  • Outpatient burst tx: 40-60 mg/day PO divided qd-bid x 3-10 days

Asthma, severe persistent

  • 7.5-60 mg PO qd-qod

Adrenal insufficiency

  • 4-5 mg/m^2 PO qd

Multiple sclerosis, acute exacerbation

  • 200 mg PO qd x 1 wk, then 80 mg PO qod x 1 mo

Alcoholic hepatitis, acute

  • 40 mg PO qd

Pediatric Dosing

Corticosteroid-responsive conditions

  • 0.14-2 mg/kg/day PO divided qd-qid

Asthma, acute

  • ED/hospital: 1-2 mg/kg/day PO divided qd-bid
  • Max: 60 mg/day, cont. until peak flow = 70% predicted
  • Outpatient burst tx: 1-2 mg/kg/day PO divided qd-bid x 3-10 days
  • Max: 60 mg/day

Asthma, severe persistent

  • 0.25-2 mg/kg PO qd-qod
  • Max 60 mg/day

Adrenal insufficiency

  • 4-5 mg/m^2 PO qd

Nephrotic syndrome

  • 60 mg/m^2/day PO divided tid x 4 wk, then 40 mg/m^2 PO qod x 4 wk

Special Populations

  • Pregnancy Rating: C
  • Lactation: Probably Safe
  • Renal Dosing
    • Adult: no adjustment
    • Pediatric: no adjustment
  • Hepatic Dosing
    • Adult: not defined
    • Pediatric: not defined

Contraindications

  • Allergy to class/drug
  • systemic fungal infection
  • active or recent varicella infection
  • active or recent measles infection
  • avoid abrupt withdrawal (high dose or long-term use)
  • caution if active infection
  • caution if TB infection
  • caution if ocular HSV
  • caution if immunosuppressed
  • caution if HTN
  • caution if CHF
  • caution if diabetes mellitus
  • caution if seizure disorder
  • caution if PUD
  • caution if ulcerative colitis
  • caution if diverticulitis
  • caution if recent intestinal anastomosis
  • caution if psychiatric disorder
  • caution if hypothyroidism
  • caution if osteoporosis
  • caution if myasthenia gravis
  • caution if renal impairment, severe
  • caution if hepatic impairment, severe
  • caution if thromboembolic disorder
  • caution if coagulation disorder
  • caution in elderly pts

Adverse Reactions

Serious

  • adrenal insufficiency
  • Cushing syndrome
  • immunosuppression
  • infection
  • HTN
  • CHF
  • diabetes mellitus
  • steroid psychosis
  • GI perforation/ulcer
  • osteopenia/osteoporosis
  • hypokalemic alkalosis
  • steroid myopathy
  • tendon rupture
  • pseudotumor cerebri
  • ICP incr.
  • seizures
  • glaucoma
  • cataracts
  • pancreatitis
  • growth suppression (long-term use, peds pts)
  • exophthalmos
  • anaphylaxis
  • withdrawal sx if abrupt D/C (high dose or long-term use)

Common

  • sodium and fluid retention
  • diaphoresis
  • headache
  • vertigo
  • insomnia
  • nervousness
  • mood swings
  • edema
  • muscle weakness
  • BP elevated
  • glucose intolerance
  • petechiae/ecchymosis
  • facial erythema
  • menstrual irregularities
  • hypokalemia
  • IOP incr.
  • impaired wound healing (long-term use)
  • Cushing syndrome
  • skin pigmentation abnormality
  • hirsutism
  • urticaria

Pharmacology

  • Half-life: 18-36h
  • Metabolism: liver, CYP450: 3A4 substrate
  • Excretion: urine
  • Mechanism of Action: exact mechanism of anti-inflammatory action unknown; inhibits multiple inflammatory cytokines; produces multiple glucocorticoid and mineralocorticoid effects

See Also

References

Retrieved from "https://www.wikem.org/w/index.php?title=Prednisolone&oldid=43131"